Hippokratia 2012; 16(3):200-204
L. Fotis, M. Xatzipsalti, A. Papadopoulou
Abstract
Eosinophilic esophagitis (EoE) is a clinical entity with continuously increasing incidence in children and adults. Diet therapy and corticosteroids are the most important therapeutic interventions currently used, while new therapies are being developed, based on the research of the disease mechanisms. In this review we assess the results of the latest clinical trials on management of patients with EoE, and the advances in the development of novel drug therapies.